New pharmaceutical candidate Lu AA37096 enters Lundbeck's development pipeline
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
Pfizer Completes Sale of Consumer Healthcare Business
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Galvus®, a new oral treatment for type 2 diabetes, receives positive opinion
- Details
- Category: Novartis
![Novartis AG Novartis AG](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Pfizer to Acquire CovX to Extend Biotherapeutics Investment
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
European Commission Approves ATRIPLA®
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Company Bristol-Myers Squibb Company](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
Avista Capital Partners to Acquire Bristol-Myers Squibb Medical Imaging for $525 Million
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Company Bristol-Myers Squibb Company](http://www.worldpharmanews.com/images/stories/logo/bms.gif)
Novo Nordisk licenses global rights to potential new haemostasis therapy
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
More Pharma News ...
- Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance - ATRIPLA®
- AstraZeneca Files Patent Infringement Actions in Response to Crestor⢠ANDAs
- Pharmion and MethylGene Present Favorable Clinical Data
- GlaxoSmithKline and OncoMed Pharmaceuticals form strategic alliance
- Pivotal Phase III Data Show Superior Efficacy of Rivaroxaban over Enoxaparin
- GSK's continued commitment to fighting HIV/AIDS results in approval of new formulations
- Pfizer and Adolor Enter into Exclusive Worldwide Collaboration